AAAAAA

   
Results: 1-15 |
Results: 15
A PHASE-II STUDY OF RECOMBINANT HUMAN INTERLEUKIN-4 FOR ADVANCED OR RECURRENT NONSMALL CELL LUNG-CANCER
Authors: VOKES EE FIGLIN R HOCHSTER H LOTZE M RYBAK ME
Citation: Ee. Vokes et al., A PHASE-II STUDY OF RECOMBINANT HUMAN INTERLEUKIN-4 FOR ADVANCED OR RECURRENT NONSMALL CELL LUNG-CANCER, The cancer journal from Scientific American, 4(1), 1998, pp. 46-51
PHARMACODYNAMICS OF TOPOISOMERASE-I INHIBITION - WESTERN-BLOT DETERMINATION OF TOPOISOMERASE-I AND CLEAVABLE COMPLEX IN PATIENTS WITH UPPERGASTROINTESTINAL MALIGNANCIES TREATED WITH TOPOTECAN
Authors: LIEBES L POTMESIL M KIM T PEASE D BUCKLEY M FRY D CHO J ADLER H DAR K ZELENIUCHJACQUOTTE A HOCHSTER H
Citation: L. Liebes et al., PHARMACODYNAMICS OF TOPOISOMERASE-I INHIBITION - WESTERN-BLOT DETERMINATION OF TOPOISOMERASE-I AND CLEAVABLE COMPLEX IN PATIENTS WITH UPPERGASTROINTESTINAL MALIGNANCIES TREATED WITH TOPOTECAN, Clinical cancer research, 4(3), 1998, pp. 545-557
PHARMACODYNAMICS OF TOPOISOMERASE-I INHIBITION - WESTERN-BLOT DETERMINATION OF TOPOISOMERASE-I AND CLEAVABLE COMPLEX IN PATIENTS WITH UPPERGASTROINTESTINAL MALIGNANCIES TREATED WITH TOPOTECAN
Authors: LIEBES L POTMESIL M KIM T PEASE D BUCKLEY M FRY D CHO J ADLER H DAR K ZELENIUCHJACQUOTTE A HOCHSTER H
Citation: L. Liebes et al., PHARMACODYNAMICS OF TOPOISOMERASE-I INHIBITION - WESTERN-BLOT DETERMINATION OF TOPOISOMERASE-I AND CLEAVABLE COMPLEX IN PATIENTS WITH UPPERGASTROINTESTINAL MALIGNANCIES TREATED WITH TOPOTECAN, Clinical cancer research, 4(3), 1998, pp. 545-557
ORAL 5-FLUOROURACIL (5-FU) PLUS ENILURACIL (776C85) IN PATIENTS WITH METASTATIC COLORECTAL-CANCER - A QUALITY-OF-LIFE (QOL) EVALUATION
Authors: SCHILSKY R BUKOWSKI R ROWINSKY E BURRIS H CRAWFORD J HOCHSTER H OROURKE M GLENDENNING A BARTON C
Citation: R. Schilsky et al., ORAL 5-FLUOROURACIL (5-FU) PLUS ENILURACIL (776C85) IN PATIENTS WITH METASTATIC COLORECTAL-CANCER - A QUALITY-OF-LIFE (QOL) EVALUATION, Annals of oncology, 9, 1998, pp. 168-168
A PHASE-II OPEN-LABEL STUDY TO EVALUATE A 28-DAY REGIMEN OF ORAL 5-FLUOROURACIL (5-FU) PLUS 776C85 FOR THE TREATMENT OF PATIENTS WITH PREVIOUSLY UNTREATED METASTATIC COLORECTAL-CANCER (CRC)
Authors: LOKICH J BECK T CHEVLEN E HOCHSTER H OROURKE M WEAVER C BELL W MCGUIRT C LEVIN J HOHNEKER J MANI S
Citation: J. Lokich et al., A PHASE-II OPEN-LABEL STUDY TO EVALUATE A 28-DAY REGIMEN OF ORAL 5-FLUOROURACIL (5-FU) PLUS 776C85 FOR THE TREATMENT OF PATIENTS WITH PREVIOUSLY UNTREATED METASTATIC COLORECTAL-CANCER (CRC), Annals of oncology, 9, 1998, pp. 169-169
EFFECT OF PROLONGED TOPOTECAN INFUSION ON TOPOISOMERASE-1 LEVELS - A PHASE-I AND PHARMACODYNAMIC STUDY
Authors: HOCHSTER H LIEBES L SPEYER J SORICH J TAUBES B ORATZ R WERNZ J CHACHOUA A BLUM RH ZELENIUCHJACQUOTTE A
Citation: H. Hochster et al., EFFECT OF PROLONGED TOPOTECAN INFUSION ON TOPOISOMERASE-1 LEVELS - A PHASE-I AND PHARMACODYNAMIC STUDY, Clinical cancer research, 3(8), 1997, pp. 1245-1252
PHASE-I STUDY OF PACLITAXEL(P) COMBINED WITH 14-DAY TOPOTECAN(T) CONTINUOUS IV (CIV) INFUSION IN PREVIOUSLY TREATED AND UNTREATED PATIENTS (PTS)
Authors: HOCHSTER H CHACHOUA A SORICH J WASSERHEIT C TAUBES B FRIEDBERG A ARBUCK S SPEYER J
Citation: H. Hochster et al., PHASE-I STUDY OF PACLITAXEL(P) COMBINED WITH 14-DAY TOPOTECAN(T) CONTINUOUS IV (CIV) INFUSION IN PREVIOUSLY TREATED AND UNTREATED PATIENTS (PTS), European journal of cancer, 33, 1997, pp. 1131-1131
SYNERGISTIC ACTIVITY OF RADIOIMMUNOTHERAPY WITH Y-90 MX-DTPA HUBRE-3 AND PROLONGED TOPOTECAN INFUSION IN HUMAN BREAST-CANCER XENOGRAFTS
Authors: NG B LIEBES L KRAMER EL WASSERHEIT C HOCHSTER H BLANK E CERIANI R FURMANSKI P
Citation: B. Ng et al., SYNERGISTIC ACTIVITY OF RADIOIMMUNOTHERAPY WITH Y-90 MX-DTPA HUBRE-3 AND PROLONGED TOPOTECAN INFUSION IN HUMAN BREAST-CANCER XENOGRAFTS, The Journal of nuclear medicine, 38(5), 1997, pp. 164-164
CLINICAL-SIGNIFICANCE OF INCREASING HISTOLOGIC SEVERITY OF ACUTE-INFLAMMATION IN THE FETAL MEMBRANES AND UMBILICAL-CORD
Authors: VANHOEVEN KH ANYAEGBUNAM A HOCHSTER H WHITTY JE DISTANT J CRAWFORD C FACTOR SM
Citation: Kh. Vanhoeven et al., CLINICAL-SIGNIFICANCE OF INCREASING HISTOLOGIC SEVERITY OF ACUTE-INFLAMMATION IN THE FETAL MEMBRANES AND UMBILICAL-CORD, PEDIATRIC PATHOLOGY & LABORATORY MEDICINE, 16(5), 1996, pp. 731-744
PHASE-II TRIAL OF PACLITAXEL AND CISPLATIN IN WOMEN WITH ADVANCED BREAST-CANCER - AN ACTIVE REGIMEN WITH LIMITING NEUROTOXICITY
Authors: WASSERHEIT C FRAZEIN A ORATZ R SORICH J DOWNEY A HOCHSTER H CHACHOUA A WERNZ J ZELENIUCHJACQUOTTE A BLUM R SPEYER J
Citation: C. Wasserheit et al., PHASE-II TRIAL OF PACLITAXEL AND CISPLATIN IN WOMEN WITH ADVANCED BREAST-CANCER - AN ACTIVE REGIMEN WITH LIMITING NEUROTOXICITY, Journal of clinical oncology, 14(7), 1996, pp. 1993-1999
PHASE I II STUDY OF PIXY321 IN COMBINATION WITH CYCLOPHOSPHAMIDE AND CARBOPLATIN IN THE TREATMENT OF OVARIAN-CANCER/
Authors: RUNOWICZ CD MANDELI J SPEYER JL WADLER S HOCHSTER H GARRISON L HOLLAND JF
Citation: Cd. Runowicz et al., PHASE I II STUDY OF PIXY321 IN COMBINATION WITH CYCLOPHOSPHAMIDE AND CARBOPLATIN IN THE TREATMENT OF OVARIAN-CANCER/, American journal of obstetrics and gynecology, 174(4), 1996, pp. 1151-1159
A PHASE-I TRIAL OF CYCLOSPHOSPHAMIDE AND CARBOPLATINUM COMBINED WITH INTERLEUKIN-3 IN WOMEN WITH ADVANCED-STAGE OVARIAN-CANCER
Authors: SPEYER JL MANDELI J HOCHSTER H RUNOWICZ CD WADLER S WALLACH R COHEN C OETTE D SORICH J DEMAKOS E GELPKE L GOLDBERG G BRUCKNER H HOLLAND J
Citation: Jl. Speyer et al., A PHASE-I TRIAL OF CYCLOSPHOSPHAMIDE AND CARBOPLATINUM COMBINED WITH INTERLEUKIN-3 IN WOMEN WITH ADVANCED-STAGE OVARIAN-CANCER, Gynecologic oncology, 56(3), 1995, pp. 387-394
PHASE-I TRIAL OF LOW-DOSE CONTINUOUS TOPOTECAN INFUSION IN PATIENTS WITH CANCER - AN ACTIVE AND WELL-TOLERATED REGIMEN
Authors: HOCHSTER H LIEBES L SPEYER J SORICH J TAUBES B ORATZ R WERNZ J CHACHOUA A RAPHAEL B VINCI RZ BLUM RH
Citation: H. Hochster et al., PHASE-I TRIAL OF LOW-DOSE CONTINUOUS TOPOTECAN INFUSION IN PATIENTS WITH CANCER - AN ACTIVE AND WELL-TOLERATED REGIMEN, Journal of clinical oncology, 12(3), 1994, pp. 553-559
EFFICACY OF CYCLOPHOSPHAMIDE (CYC) AND FLUDARABINE (FAMP) AS 1ST LINETHERAPY OF LOW-GRADE NON-HODGKINS-LYMPHOMA (NHL) - ECOG 1491
Authors: HOCHSTER H OKEN M BENNETT J WOLF B GORDON L RAPHAEL B GENCARELLI P CASSILETH P
Citation: H. Hochster et al., EFFICACY OF CYCLOPHOSPHAMIDE (CYC) AND FLUDARABINE (FAMP) AS 1ST LINETHERAPY OF LOW-GRADE NON-HODGKINS-LYMPHOMA (NHL) - ECOG 1491, Blood, 84(10), 1994, pp. 10000383-10000383
MANAGEMENT OF HYPOCALCEMIC EFFECTS OF WR2721 ADMINISTERED ON A DAILY TIMES 5 SCHEDULE WITH CISPLATIN AND RADIATION-THERAPY
Authors: WADLER S HAYNES H BEITLER JJ GOLDBERG G HOLLAND JF HOCHSTER H BRUCKNER H MANDELI J SMITH H RUNOWICZ C
Citation: S. Wadler et al., MANAGEMENT OF HYPOCALCEMIC EFFECTS OF WR2721 ADMINISTERED ON A DAILY TIMES 5 SCHEDULE WITH CISPLATIN AND RADIATION-THERAPY, Journal of clinical oncology, 11(8), 1993, pp. 1517-1522
Risultati: 1-15 |